HydroxyzineQT interval prolongation: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1540卷 / 1期

关键词：

D O I：

10.1007/s40278-015-8004-y

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：156 / 156

相关论文

共 50 条

[41] EpinephrineQT interval prolongation: case report
Reactions Weekly, 2016, 1629 (1) : 109 - 109
[42] AzithromycinQTc interval prolongation: case report
Reactions Weekly, 2016, 1623 (1) : 39 - 39
[43] ClindamycinQT interval prolongation: case report
Reactions Weekly, 2019, 1740 (1) : 100 - 100
[44] AmiodaroneQTc interval prolongation: case report
Reactions Weekly, 2019, 1774 (1) : 24 - 24
[45] ClozapineQT interval prolongation: case report
Reactions Weekly, 2019, 1780 (1) : 112 - 112
[46] HydroxychloroquineQT interval prolongation: case report
Reactions Weekly, 2023, 1980 (1) : 207 - 207
[47] EscitalopramQTc interval prolongation: case report
Reactions Weekly, 2012, 1401 (1) : 16 - 16
[48] FlecainideMaternal QT interval prolongation in association with prolongation of PR interval: case report
Reactions Weekly, 2017, 1638 (1) : 99 - 99
[49] Haloperidol/loperamideCardiotoxicity, QT interval prolongation and QRS interval prolongation: case report
Reactions Weekly, 2017, 1668 (1) : 197 - 197
[50] GalantamineFirst report of QTc interval prolongation: case report
Reactions Weekly, 2006, 1097-1098 (1) : 15 - 15

← 1 2 3 4 5 →